文献速递临床试验与 GCP流行病学与生物统计

在临床试验分析中使用主分层

Using principal stratification in analysis of clinical trials.
PubMed 文献 · Stat Med · 2022-06-13

ICH E9(R1) 附加文件(2019)将主分层(PS)列为处理伴发事件的五种策略之一,本文以教程形式统一描述 PS、强调其效应估计依赖强假设并剖析假设后果、概述多种 PS 分析方法并用真实临床试验实例演示。

要点

  • ICH E9(R1)(2019)将主分层列为处理伴发事件的五种策略之一。
  • 主分层内效应估计依赖强假设,需理解何种情境下假设合理。
  • 教程概述多种主分层分析方法,并以真实临床试验实例说明。

核心结论

  • 理解主分层的优势、局限与假设对临床试验研究者群体很重要。
  • 主分层内效应估计依赖强假设,需检视这些假设的后果以判断特定假设在何种情境下合理。

研究设计与样本

  • 教程类文章,系统介绍主分层框架并综述实验性与观察性研究中已开发的主分层方法。
  • 以真实临床试验实例演示多种主分层分析方法,部分方法的实现代码见补充材料。

主要发现

  • 主分层被 ICH E9(R1) 附加文件(2019)列为处理伴发事件的五种策略之一。
  • 不同研究领域的主分层应用使用了多样的工具与假设。
  • 教程对主分层给出连贯统一的描述,并概述多种关键的主分层分析方法。

局限性

  • 主分层内效应估计依赖强假设,教程重点检视这些假设的后果以理解其合理情境。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The ICH E9(R1) addendum (2019) proposed principal stratification (PS) as one of five strategies for dealing with intercurrent events. Therefore, understanding the strengths, limitations, and assumptions of PS is important for the broad community of clinical trialists. Many approaches have been developed under the general framework of PS in different areas of research, including experimental and observational studies. These diverse applications have utilized a diverse set of tools and assumptions. Thus, need exists to present these approaches in a unifying manner. The goal of this tutorial is threefold. First, we provide a coherent and unifying description of PS. Second, we emphasize that estimation of effects within PS relies on strong assumptions and we thoroughly examine the consequences of these assumptions to understand in which situations certain assumptions are reasonable. Finally, we provide an overview of a variety of key methods for PS analysis and use a real clinical trial example to illustrate them. Examples of code for implementation of some of these approaches are given in Supplemental Materials.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. Lipkovich I, Ratitch B, Qu Y, et al. Using principal stratification in analysis of clinical trials. Stat Med. 2022. PMID: 35851717. doi:10.1002/sim.9439

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。